
pmid: 12586640
With the use of in vitro receptor autoradiography, this study aims at determining whether the higher level of kinin B2receptor density in the spinal cord of the spontaneously hypertensive rat (SHR) is secondary to arterial hypertension and whether chronic treatment with angiotensin I-converting enzyme inhibitors (ACEI) can regulate neuronal B1and B2receptors. SHR received, from the age of 4 wk, one of the two ACEI (lisinopril or zofenopril, 10 mg · kg−1· day−1) or for comparison, the selective AT1antagonist (losartan, 20 mg · kg−1· day−1) in their drinking water for a period of 4, 12, and 20 wk. Age-matched untreated SHR and Wistar-Kyoto rats (WKY) were used as controls. B2receptor binding sites in most laminae were higher in SHR than in WKY from the age of 8 to 24 wk. Whereas B1receptor binding sites were significantly present in young SHR and WKY, they were barely detectable in adult rats. ACEI (16 and 24 wk) and AT1antagonist (24 wk) enhanced the number of B2without changing B1receptor binding sites. However, at 8 wk the three treatments significantly increased B1and decreased B2receptors in lamina I. It is concluded that 1) the higher density of B2receptors in the spinal cord of SHR is not due to hypertension, 2) kinin receptors are regulated differently by ACEI in neuronal and vascular tissues, and 3) aging may have a profound impact on levels of B1and B2receptors in the rat spinal cord.
Male, Receptor, Bradykinin B2, Receptors, Bradykinin, Body Weight, Angiotensin-Converting Enzyme Inhibitors, Blood Pressure, Receptor, Bradykinin B1, Rats, Inbred WKY, Losartan, Rats, Species Specificity, Spinal Cord, Rats, Inbred SHR, Hypertension, Animals, Autoradiography, Antihypertensive Agents, Bradykinin Receptor Antagonists
Male, Receptor, Bradykinin B2, Receptors, Bradykinin, Body Weight, Angiotensin-Converting Enzyme Inhibitors, Blood Pressure, Receptor, Bradykinin B1, Rats, Inbred WKY, Losartan, Rats, Species Specificity, Spinal Cord, Rats, Inbred SHR, Hypertension, Animals, Autoradiography, Antihypertensive Agents, Bradykinin Receptor Antagonists
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 22 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
